Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - AVADEL PHARMACEUTICALS PLCex99_2-06022017.htm
8-K - FORM 8K - AVADEL PHARMACEUTICALS PLCf8k-06022017.htm
Exhibit 99.1
 

              
            
                                    June 2, 2017
 
Avadel Pharmaceuticals plc
Block 10-1, Blanchardstown Corporate Park
Ballycoolin, Dublin 15, Ireland


To our Shareholders:

We are forwarding herewith a copy of the Irish Statutory Financial Statements of Avadel Pharmaceuticals plc (the "Company") for the period beginning December 1, 2015 (the date of incorporation) through December 31, 2016, along with the related directors' and independent auditor's reports. These Irish Statutory Financial Statements may be considered to be part of the proxy materials which were furnished to you under cover of our letter dated May 26, 2017, namely, (a) the notice of the annual general meeting of shareholders (the "Meeting") of the Company to be held Wednesday, June 28, 2017 at 12:00 Noon (Irish Standard Time) at the offices of Arthur Cox, Ten Earlsfort Terrace, Dublin 2, D02 T380, Ireland, (b) the proxy statement relating to the matters to be considered at the Meeting and containing certain other information, (c) a proxy card (for use by holders of our ordinary shares) or a voting instruction card (for use by holders of our American Depositary Shares), as applicable, and (d) a copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.
Additional copies of the materials described above may be obtained without charge by writing to the Corporate Secretary of Avadel Pharmaceuticals plc at Block 10-1, Blanchardstown Corporate Park, Ballycoolin, Dublin 15, Ireland or downloaded from our website at www.Avadel.com.
 

 
Very truly yours,

/s/ Phillandas T. Thompson
Phillandas T. Thompson
Senior Vice President, General Counsel,
Corporate Secretary